NCT05403177 Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) Status RECRUITING Phase N/A
NCT05393999 SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations Status WITHDRAWN Phase PHASE2
NCT05375253 Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Malignancies Status WITHDRAWN Phase PHASE1
NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease Status RECRUITING Phase N/A
NCT05362331 Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy Status WITHDRAWN Phase NA
NCT05309213 Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia Status UNKNOWN Phase PHASE1/PHASE2
NCT05282459 Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation Status COMPLETED Phase PHASE1/PHASE2
NCT05268003 A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT05237986 Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy Status RECRUITING Phase N/A
NCT05203809 Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies Status UNKNOWN Phase N/A
NCT05190653 Early Integration of Palliative and Supportive Care in Cellular Therapy Status RECRUITING Phase NA
NCT05179824 Tempus Priority Study: A Pan-tumor Observational Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05168904 A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) Status SUSPENDED Phase PHASE1/PHASE2
NCT05131815 The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors Status COMPLETED Phase NA
NCT05123001 Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events Status COMPLETED Phase N/A
NCT05064787 Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy Status COMPLETED Phase NA
NCT05063591 Removing Transfusion Dependence as a Barrier to Hospice Enrollment Status COMPLETED Phase NA
NCT05061147 A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Status UNKNOWN Phase PHASE1/PHASE2
NCT05049785 Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone Status COMPLETED Phase EARLY_PHASE1